![Lislotte Theorell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lislotte Theorell
Profile
Lislotte Theorell worked as a Director of Quality Management at SentoClone AB.
Former positions of Lislotte Theorell
Companies | Position | End |
---|---|---|
SentoClone AB
![]() SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Corporate Officer/Principal | 31/12/2012 |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
SentoClone AB
![]() SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
- Stock Market
- Insiders
- Lislotte Theorell